JPMorgan Raises Galderma Target Price to CHF 220 From CHF 190
JPMorgan raised its target price for Galderma Group AG to CHF 220 from CHF 190.
Related stories
High Quality Food reports Q3 2026 revenue of €4.6 million
M impact | EQUITY | Oct 29, 2026, 04:44 PM UTC
X-FAB Silicon Foundries Reports Third-Quarter Revenue of $194.4 Million
M impact | EQUITY | Oct 29, 2026, 04:43 PM UTC
Pilgrim’s Pride Q3 Profit Falls
M impact | EQUITY | Oct 29, 2026, 04:42 PM UTC
NX Filtration Launches Private Share Placement of Up to EUR 20 Million
NX Filtration launched a private share placement of up to EUR 20 million.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC
X-FAB Q3 Operating Profit Falls 82% Year Over Year
X-FAB reported Q3 2026 operating profit down 82% year over year.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC
C & I Leasing Reports Q3 Gross Earnings of 12.95 Billion Naira
The company reported Q3 profit from continuing operations before tax of 983.5 million naira.
M impact | EQUITY | Oct 29, 2026, 04:41 PM UTC